BCM
CRL icon

Brown Capital Management’s Charles River Laboratories CRL Stock Holding History

Brown Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,484
Closed -$223K – 88
2025
Q1 		$223K Sell
1,484
-675
-31% -$113K 0.01% 102
2024
Q4 		$399K Sell
2,159
-4,387
-67% -$845K 0.01% 96
2024
Q3 		$1.29M Sell
6,546
-13,542
-67% -$2.81M 0.03% 70
2024
Q2 		$4.15M Sell
20,088
-2,876
-13% -$652K 0.08% 60
2024
Q1 		$6.22M Sell
22,964
-185
-0.8% -$44.2K 0.11% 54
2023
Q4 		$5.47M Sell
23,149
-766
-3% -$151K 0.08% 52
2023
Q3 		$4.69M Buy
23,915
+1,725
+8% +$354K 0.07% 52
2023
Q2 		$4.67M Buy
22,190
+7,727
+53% +$1.54M 0.07% 55
2023
Q1 		$2.92M Buy
14,463
+1,699
+13% +$385K 0.04% 63
2022
Q4 		$2.78M Sell
12,764
-2,427
-16% -$530K 0.05% 62
2022
Q3 		$2.99M Sell
15,191
-13
-0.1% -$2.81K 0.04% 59
2022
Q2 		$3.25M Buy
15,204
+1,195
+9% +$292K 0.04% 54
2022
Q1 		$3.98M Buy
14,009
+399
+3% +$123K 0.04% 55
2021
Q4 		$5.13M Buy
13,610
+354
+3% +$138K 0.04% 55
2021
Q3 		$5.47M Buy
13,256
+2,021
+18% +$839K 0.04% 52
2021
Q2 		$4.16M Buy
11,235
+570
+5% +$190K 0.03% 54
2021
Q1 		$3.09M Hold
10,665
– – 0.02% 65
2020
Q4 		$2.67M Buy
10,665
+330
+3% +$78.6K 0.02% 67
2020
Q3 		$2.34M Buy
10,335
+243
+2% +$50.4K 0.02% 63
2020
Q2 		$1.76M Buy
10,092
+3,649
+57% +$582K 0.02% 72
2020
Q1 		$813K Buy
6,443
+381
+6% +$57.1K 0.01% 83
2019
Q4 		$686K Hold
6,062
– – 0.01% 96
2019
Q3 		$802K Buy
+6,062
New +$813K 0.01% 93

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Brown Capital Management's CRL Position: Q2 2025 in Review

Brown Capital Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 1,484 shares — an estimated $223K sold.

Brown Capital Management first reported a position in CRL in Q3 2019 and held it in 23 quarters. The position peaked at $6.22M in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Brown Capital Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Brown Capital Management sold 1,484 Charles River Laboratories shares in Q2 2025, an estimated $223K.
  • Brown Capital Management first reported a position in Charles River Laboratories in Q3 2019 and held it in 23 quarters.
  • Brown Capital Management's Charles River Laboratories position peaked at $6.22M in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Brown Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.